Related Experiment Video
Updated: Jul 7, 2026

An Electrophysiology Protocol to Measure Reward Anticipation and Processing in Children
Published on: October 4, 2018
Neurophysiological Markers of Reward Processing Can Inform Preclinical Neurorehabilitation Approaches for Cognitive
Miranda Francoeur Koloski1,2,3, Reyana Menon1, Victoria Krasnyanskiy1
1Mental Health Service, VA San Diego Healthcare System, La Jolla, CA 92161, USA.
Abstract:
Brain stimulation therapies may be used to correct motor, social, emotional, and cognitive consequences of traumatic brain injury (TBI). Neuromodulation applied with anatomical specificity can ameliorate desired symptoms while leaving functional circuits intact. Before applying precision medicine approaches, preclinical animal studies are needed to explore potential neurophysiological signatures that could be modulated with neurostimulation. This review discusses potential neural signatures of cognition, particularly reward processing, which is chronically impaired after brain injury. Electrophysiology, compared to other types of biomarkers, can detect deficits missed by structural measures, holds translational potential between humans and animals, and directly informs neuromodulatory treatments. Disturbances in oscillatory activity underscore structural, molecular, and behavioral impairments seen following TBI. For instance, cortico-striatal beta frequency activity (15-30 Hz) during reward processing represents subjective value and is chronically disturbed after frontal TBI in rodents. We use the example of evoked beta oscillations in the cortico-striatal network as a putative marker of reward processing that could be targeted with electrical stimulation to improve decision making after TBI. This review highlights the necessity of collecting electrophysiological data in preclinical models to understand the underlying mechanisms of cognitive behavioral deficits after TBI and to develop targeted stimulation treatments in humans.
Related Concept Videos
Neuroplasticity
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).

